| Fund | Type | Gross assets | Min. |
|---|---|---|---|
| Biopharma Credit Investments V (master) LP | Private Equity | $1.71B | — |
| Name | Title | Ownership | Since |
|---|---|---|---|
| Douglas Yeon Kim Control | Chief Compliance Officer, General Counsel | Under 5% | 2022 |
| Martin Gershon Friedman Control | Limited Partner | 25-50% | 2013 |
| Pablo Gerardo Legorreta Control | Limited Partner | 25-50% | 2009 |
Pharmakon Advisors, LP reports $2.9 billion in regulatory assets under management on its Form ADV.
Pharmakon Advisors, LP manages 1 private funds with combined gross assets of $1.7 billion.
Pharmakon Advisors, LP reports 13 employees.
Pharmakon Advisors, LP is based in New York, NY and has been SEC-registered since 2012.
Pharmakon Advisors, LP is not required to publicly disclose fund returns. Form ADV filings include assets, ownership, and service providers, shown above.
| Address | 110 East 59th Street, 28th Floor, New York, NY 10022-1304 |
| Phone | 212-883-2296 |
| Fax | 917-210-4048 |
| Office hours | 9:00 a.m. - 6:00 p.m. |
| SEC region | New York Regional Office (NYRO) |
| Discloses disciplinary history | No |
| Discretionary | $2.91B |
| Non-discretionary | $0 |
| Total (RAUM) | $2.91B |